Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

BMO Capital Maintains Outperform on Linde, Raises Price Target to $510

Author: Benzinga Newsdesk | March 08, 2024 12:20pm
BMO Capital analyst John McNulty maintains Linde (NASDAQ:LIN) with a Outperform and raises the price target from $460 to $510.

Posted In: LIN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist